Danish company Novo Nordisk is set to launch Wegovy for weight loss, in India on Tuesday. The injectable product, called the ...

Wegovy is only approved for obesity in India. Novo Nordisk has no immediate plans to launch Ozempic for type 2 diabetes, though it is exploring oral semaglutide for obesity.

Danish pharmaceutical company Novo Nordisk on Tuesday announced the launch of its weight-loss drug Wegovy, an injectable ...

Wegovy is the first drug in India approved for both weight management and risk reduction of major adverse cardiovascular ...

Novo Nordisk has officially launched its anti-obesity drug Wegovy in India ahead of patent expiry. This move aims to tackle rising obesity rates while facing competition from rival drugs.

Danish drugmaker Novo Nordisk officially launched its blockbuster weight-loss drug Wegovy on Tuesday as a once-a-week ...

Stock markets have rallied after U.S. President Donald Trump announced a ceasefire in the Israel-Iran conflict, although the ...